You are here
We have platform technology and research tool opportunities, for use in a range of therapeutic and diagnostic applications, available for licensing.
Cancer Research UK is seeking a licensing partner to progress our CDC2L1/2 (CDK11B/A) inhibitors to pre-clinical investigation as novel warhead payloads for the development of Antibody-Drug ConjugaRead more
The patented technology is available to license on a non-exclusive basis.Read more
The Optimam Mammography Image Database (OMI-DB) has been created to support research involving medical imaging with the aim of optimising the use of existing and adoption of new X-ray imaging technRead more
Our tracer 18F-FDMP is based on a pivalic acid structure and is designed for imaging the first steps of lipid metabolism.Read more